BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Yenilikçi Onkoloji Derneği - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.yenilikcionkolojidernegi.com
X-WR-CALDESC:Yenilikçi Onkoloji Derneği için etkinlikler
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Moscow
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:MSK
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260915T190000
DTEND;TZID=Europe/Moscow:20260915T200000
DTSTAMP:20260818T072054Z
CREATED:20260818T072053Z
LAST-MODIFIED:20260818T072054Z
UID:30794-1789498800-1789502400@www.yenilikcionkolojidernegi.com
SUMMARY:HER2 POZİTİF MEME KANSERİNİN TEDAVİSİNDE GÜNCEL GELİŞMELER
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/her2-pozitif-meme-kanserinin-tedavisinde-guncel-gelismeler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260623T190000
DTEND;TZID=Europe/Moscow:20260623T200000
DTSTAMP:20260413T094202Z
CREATED:20260305T093151Z
LAST-MODIFIED:20260413T094202Z
UID:30226-1782241200-1782244800@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK MEME KANSERİNDE TEDAVİ YÖNTEMİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-meme-kanserinde-tedavi-yontemi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260612T190000
DTEND;TZID=Europe/Moscow:20260612T200000
DTSTAMP:20260413T094226Z
CREATED:20260305T093309Z
LAST-MODIFIED:20260413T094226Z
UID:30229-1781290800-1781294400@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK KOLOREKTAL KANSERİN TEDAVİSİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-kolorektal-kanserin-tedavisi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260522T190000
DTEND;TZID=Europe/Moscow:20260522T200000
DTSTAMP:20260413T094254Z
CREATED:20260127T074220Z
LAST-MODIFIED:20260413T094254Z
UID:30091-1779476400-1779480000@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK AKCİĞER KANSERİNDE ALK HEDEFLİ TEDAVİLER
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-akciger-kanserinde-alk-hedefli-tedaviler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260520T190000
DTEND;TZID=Europe/Moscow:20260520T200000
DTSTAMP:20260519T174052Z
CREATED:20260519T174002Z
LAST-MODIFIED:20260519T174052Z
UID:30622-1779303600-1779307200@www.yenilikcionkolojidernegi.com
SUMMARY:YOD FELLOW AKADEMİSİ: MAKALE TARTIŞMA OTURUMU
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/yod-fellow-akademisi-makale-tartisma-oturumu/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260518T190000
DTEND;TZID=Europe/Moscow:20260518T200000
DTSTAMP:20260413T094400Z
CREATED:20260413T094359Z
LAST-MODIFIED:20260413T094400Z
UID:30470-1779130800-1779134400@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK PROSTAT KANSERİNİN TEDAVİ ALGORİTMASI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-prostat-kanserinin-tedavi-algoritmasi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260511T190000
DTEND;TZID=Europe/Moscow:20260511T200000
DTSTAMP:20260326T122121Z
CREATED:20260216T140754Z
LAST-MODIFIED:20260326T122121Z
UID:30182-1778526000-1778529600@www.yenilikcionkolojidernegi.com
SUMMARY:MOLEKÜLER ONKOLOJİ ÇAĞINDA KANSER TEDAVİSİNDE KEMOTERAPİNİN ETKİNLİĞİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/molekuler-onkoloji-caginda-kanser-tedavisinde-kemoterapinin-etkinligi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260505T190000
DTEND;TZID=Europe/Moscow:20260505T200000
DTSTAMP:20260430T070752Z
CREATED:20260127T074138Z
LAST-MODIFIED:20260430T070752Z
UID:30087-1778007600-1778011200@www.yenilikcionkolojidernegi.com
SUMMARY:KANSER TEDAVİSİNDE DESTEKLEYİCİ YAKLAŞIMLAR
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/kanser-tedavisinde-destekleyici-yaklasimlar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260427T190000
DTEND;TZID=Europe/Moscow:20260427T200000
DTSTAMP:20260326T122036Z
CREATED:20260305T093515Z
LAST-MODIFIED:20260326T122036Z
UID:30232-1777316400-1777320000@www.yenilikcionkolojidernegi.com
SUMMARY:MESANE KANSERİNİN TEDAVİSİNDE İMMUNOTERAPİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/mesane-kanserinin-tedavisinde-immunoterapi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260420T190000
DTEND;TZID=Europe/Moscow:20260420T200000
DTSTAMP:20260415T062331Z
CREATED:20260305T092725Z
LAST-MODIFIED:20260415T062331Z
UID:30223-1776711600-1776715200@www.yenilikcionkolojidernegi.com
SUMMARY:İMMUNOTERAPİ ÇAĞINDA METASTATİK KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİNİN TEDAVİSİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/immunoterapi-caginda-metastatik-kucuk-hucreli-disi-akciger-kanserinin-tedavisi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260413T190000
DTEND;TZID=Europe/Moscow:20260413T200000
DTSTAMP:20260325T064231Z
CREATED:20260127T073950Z
LAST-MODIFIED:20260325T064231Z
UID:30081-1776106800-1776110400@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK RENAL HÜCRELİ KANSERDE GÜNCEL YAKLAŞIM
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-renal-hucreli-kanserde-guncel-yaklasim/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260411T190000
DTEND;TZID=Europe/Moscow:20260411T200000
DTSTAMP:20260410T122222Z
CREATED:20251229T100856Z
LAST-MODIFIED:20260410T122222Z
UID:30039-1775934000-1775937600@www.yenilikcionkolojidernegi.com
SUMMARY:MESANE KANSERİNDE TEDAVİ YAKLAŞIMI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/mesane-kanserinde-tedavi-yaklasimi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260406T190000
DTEND;TZID=Europe/Moscow:20260406T200000
DTSTAMP:20260326T121827Z
CREATED:20260127T073829Z
LAST-MODIFIED:20260326T121827Z
UID:30078-1775502000-1775505600@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK KOLOREKTAL KANSERİN TEDAVİSİNE GENEL BAKIŞ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-kolorektal-kanserin-tedavisine-genel-bakis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260330T190000
DTEND;TZID=Europe/Moscow:20260330T200000
DTSTAMP:20260325T064210Z
CREATED:20251209T191235Z
LAST-MODIFIED:20260325T064210Z
UID:29994-1774897200-1774900800@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK MEME KANSERİNİN TEDAVİSİNDE YENİLİKLER
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-meme-kanserinin-tedavisinde-yenilikler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260325T190000
DTEND;TZID=Europe/Moscow:20260325T200000
DTSTAMP:20260220T072602Z
CREATED:20260220T072600Z
LAST-MODIFIED:20260220T072602Z
UID:30211-1774465200-1774468800@www.yenilikcionkolojidernegi.com
SUMMARY:Fellow Akademisi: Onkolojide Klinik Karar Pratiği
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/fellow-akademisi-onkolojide-klinik-karar-pratigi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260323T190000
DTEND;TZID=Europe/Moscow:20260323T200000
DTSTAMP:20251209T191054Z
CREATED:20251209T191053Z
LAST-MODIFIED:20251209T191054Z
UID:29988-1774292400-1774296000@www.yenilikcionkolojidernegi.com
SUMMARY:OVER KANSERİNİN TEDAVİSİNDE İDAME TEDAVİLER
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/over-kanserinin-tedavisinde-idame-tedaviler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260318T190000
DTEND;TZID=Europe/Moscow:20260318T200000
DTSTAMP:20260305T092316Z
CREATED:20260305T092253Z
LAST-MODIFIED:20260305T092316Z
UID:30220-1773860400-1773864000@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK PROSTAT KANSERİNİN TEDAVİ ALGORİTMASIMETASTATİK PROSTAT KANSERİNİN TEDAVİ ALGORİTMASI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-prostat-kanserinin-tedavi-algoritmasimetastatik-prostat-kanserinin-tedavi-algoritmasi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260217T190000
DTEND;TZID=Europe/Moscow:20260217T200000
DTSTAMP:20260216T144653Z
CREATED:20251125T161218Z
LAST-MODIFIED:20260216T144653Z
UID:29583-1771354800-1771358400@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK MEME KANSERİNİN TEDAVİSİNDE HORMONAL TEDAVİLER
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-meme-kanserinin-tedavisinde-hormonal-tedaviler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260209T190000
DTEND;TZID=Europe/Moscow:20260209T200000
DTSTAMP:20260208T163353Z
CREATED:20251125T161143Z
LAST-MODIFIED:20260208T163353Z
UID:29581-1770663600-1770667200@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİNDE İMMUNOTERAPİ YAKLAŞIMLARI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastatik-kucuk-hucreli-disi-akciger-kanserinde-immunoterapi-yaklasimlari/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260203T190000
DTEND;TZID=Europe/Moscow:20260203T200000
DTSTAMP:20260205T110639Z
CREATED:20251125T161042Z
LAST-MODIFIED:20260205T110639Z
UID:29579-1770145200-1770148800@www.yenilikcionkolojidernegi.com
SUMMARY:OVER KANSERİNİN TEDAVİSİNDE PARP İNHİBİTÖRLERİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/over-kanserinin-tedavisinde-parp-inhibitorleri/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260127T190000
DTEND;TZID=Europe/Moscow:20260127T200000
DTSTAMP:20251127T181019Z
CREATED:20251127T094324Z
LAST-MODIFIED:20251127T181019Z
UID:29817-1769540400-1769544000@www.yenilikcionkolojidernegi.com
SUMMARY:EVRE 3 KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSEİNDE GÜNCEL TEDAVİ MODALİTESİ: KEMORADYOTERAPİDEN İMUNOTERAPİYE
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/evre-3-kucuk-hucreli-disi-akciger-kanseinde-guncel-tedavi-modalitesi-kemoradyoterapiden-imunoterapiye/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260120T190000
DTEND;TZID=Europe/Moscow:20260120T200000
DTSTAMP:20251125T160818Z
CREATED:20251125T160815Z
LAST-MODIFIED:20251125T160818Z
UID:29577-1768935600-1768939200@www.yenilikcionkolojidernegi.com
SUMMARY:HORMON DUYARLI METASTATİK PROSTAT KANSERİ HASTALARDA TEDAVİ YAKLAŞIMLARI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/hormon-duyarli-metastatik-prostat-kanseri-hastalarda-tedavi-yaklasimlari/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20260106T190000
DTEND;TZID=Europe/Moscow:20260106T200000
DTSTAMP:20251125T160720Z
CREATED:20251125T160716Z
LAST-MODIFIED:20251125T160720Z
UID:29575-1767726000-1767729600@www.yenilikcionkolojidernegi.com
SUMMARY:HORMON DUYARLI METASTATİK PROSTAT KANSERİ’NİN TEDAVİSİNE GENEL BAKIŞ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/hormon-duyarli-metastatik-prostat-kanserinin-tedavisine-genel-bakis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251223T190000
DTEND;TZID=Europe/Moscow:20251223T200000
DTSTAMP:20251126T185124Z
CREATED:20251125T160603Z
LAST-MODIFIED:20251126T185124Z
UID:29573-1766516400-1766520000@www.yenilikcionkolojidernegi.com
SUMMARY:HR+/HER2-NEGATİF METASTATİK MEME KANSERİNDE BİRİNCİ BASAMAKTA CDK4/6 İNHİBİTÖRLERİNİN ROLÜ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/hr-her2-negatif-metastatik-meme-kanserinde-birinci-basamakta-cdk4-6-inhibitorlerinin-rolu/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251215T190000
DTEND;TZID=Europe/Moscow:20251215T200000
DTSTAMP:20251126T172944Z
CREATED:20251125T160433Z
LAST-MODIFIED:20251126T172944Z
UID:29571-1765825200-1765828800@www.yenilikcionkolojidernegi.com
SUMMARY:METASTATİK HORMON DUYARLI PROSTAT KANSERİNDE TEDAVİ PARADİGMALARI
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/metastik-hormon-duyarli-prostat-kanserinde-tedavi-paradigmalari/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251201T190000
DTEND;TZID=Europe/Moscow:20251201T200000
DTSTAMP:20251128T084613Z
CREATED:20251125T160321Z
LAST-MODIFIED:20251128T084613Z
UID:29568-1764615600-1764619200@www.yenilikcionkolojidernegi.com
SUMMARY:VAKALARLA MOLEKÜLER TEST YORUMLAMA
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/vakalarla-molekuler-test-yorumlama/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251120T190000
DTEND;TZID=Europe/Moscow:20251120T200000
DTSTAMP:20251125T155621Z
CREATED:20251125T155617Z
LAST-MODIFIED:20251125T155621Z
UID:29555-1763665200-1763668800@www.yenilikcionkolojidernegi.com
SUMMARY:TRİPLE NEGATİF METASTATİK MEME KANSERİNDE YENİ TEDAVİ SEÇENEKLERİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/triple-negatif-metastatik-meme-kanserinde-yeni-tedavi-secenekleri/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251103T190000
DTEND;TZID=Europe/Moscow:20251103T200000
DTSTAMP:20251125T154849Z
CREATED:20251125T154756Z
LAST-MODIFIED:20251125T154849Z
UID:29541-1762196400-1762200000@www.yenilikcionkolojidernegi.com
SUMMARY:HR+/HER2-NEGATİF METASTATİK MEME KANSERİNDE CDK4/6 İNHİBİTÖRLERİ: KİŞİSELLEŞTİRİLMİŞ TEDAVİ VE HASTA BAZLI KARARLAR
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/hr-her2-negatif-metastatik-meme-kanserinde-cdk4-6-inhibitorleri-kisisellestirilmis-tedavi-ve-hasta-bazli-kararlar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251027T190000
DTEND;TZID=Europe/Moscow:20251027T200000
DTSTAMP:20251125T154935Z
CREATED:20251125T145522Z
LAST-MODIFIED:20251125T154935Z
UID:29537-1761591600-1761595200@www.yenilikcionkolojidernegi.com
SUMMARY:DRİVER MUTASYONU NEGATİF\, PD-L1 YÜKSEK METASTATİK KHDAK’DE BİRİNCİ BASAMAKTA TEDAVİ SEÇENEKLERİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/driver-mutasyonu-negatif-pd-l1-yuksek-metastatik-khdakde-birinci-basamakta-tedavi-secenekleri/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Moscow:20251010T190000
DTEND;TZID=Europe/Moscow:20251010T200000
DTSTAMP:20251125T155515Z
CREATED:20251125T145323Z
LAST-MODIFIED:20251125T155515Z
UID:29535-1760122800-1760126400@www.yenilikcionkolojidernegi.com
SUMMARY:DRİVER MUTASYONU NEGATİF\, PD-L1 <%50 OLAN METASTATİK KHDAK’DE BİRİNCİ BASAMAKTA İMMÜNOTERAPİ SEÇENEKLERİ
DESCRIPTION:
URL:https://www.yenilikcionkolojidernegi.com/etkinlik/driver-mutasyonu-negatif-pd-l1-%50-olan-metastatik-khdakde-birinci-basamakta-immunoterapi-secenekleri/
END:VEVENT
END:VCALENDAR